Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome
Turkish Journal of Medical Sciences · 26.10.2023 · 53 (5) · 1194-1204
DOI: 10.55730/1300-0144.5685 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 26.10.2023. Verfasst von Emrah Şenel und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Surgical Medical Sciences, Faculty of Medicine, Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/aim: The clinical presentation of pediatric coronavirus disease 2019 (COVID-19) is associated with a milder disease course than the adult COVID-19 syndrome. The disease course of COVID-19 has three clinicobiological phases: initiation, propagation, and complication. This study aimed to assess the pathobiological alterations affecting the distinct clinical courses of COVID-19 in pediatric age groups versus the adult population. We hypothesized that critical biogenomic marker expressions drive the mild clinical presentations of pediatric COVID-19. Materials and methods: Blood samples were obtained from 72 patients with COVID-19 hospitalized at Ankara City Hospital between March and July 2021. Peripheral blood mononuclear cells were isolated using Ficoll-Paque and density-gradient sedimentation. The groups were compared using a t-test and limma analyses. Mean standardized gene expression levels were used to hierarchically cluster genes employing Euclidean Gene Cluster 3.0. The expression levels of identified genes were determined using reverse transcriptionpolymerase chain reaction.
Results
This study found that ANPEP gene expression was significantly downregulated in the pediatric group (p < 0.05, FC: 1.57) and IGF2R gene expression was significantly upregulated in the adult group (p < 0.05, FC: 2.98). The study results indicated that the expression of critical biogenomic markers, such as the first-phase (ACE2 and ANPEP) and second-phase (EGFR and IGF2R) receptor genes, was crucial in the genesis of mild clinical presentations of pediatric COVID-19. ANPEP gene expression was lower in pediatric COVID-19.
Conclusion
The interrelationship between the ANPEP and ACE2 genes may prevent the progression of COVID-19 from initiation to the propagating phase in pediatric patients. High IGF2R gene expression could potentially contribute to a protective effect and may be a contributing factor for the mild clinical course observed in pediatric patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Surgical Medical Sciences, Faculty of Medicine, Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkiye.
- Department of Biochemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkiye.
- Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
- Department of Economics, Faculty of Economics and Administrative Sciences, Hacettepe University, Ankara, Turkiye.
- Department of Medical Microbiology, Faculty of Medicine, Lokman Hekim University, Ankara, Turkiye.
- Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkiye.
ORCID-Profile: Emrah Şenel, Seyhan Türk, Ümit Yavuz Malkan, Mustafa Çağrı Peker, Can Türk, Hatice Rahmet Güner, Gülberk Uçar, Seval Izdeş, Bircan Kayaaslan, Gülsüm İclal Bayhan, Serhat Emeksiz, İmran Hasanoğlu, Şerife Gökbulut Bektaş, Şeyma Bütün Türk, Serhan Özcan, Ahmet Ertürk, Ahmet Gökhan Akdağ, Ayşegül Yilmaz, İbrahim Celalettin Haznedaroğlu
Zitieren
APA
Şenel, E., Türk, S., Malkan, Ü. Y., Peker, M. Ç., Türk, C., Güner, H. R., Uçar, G., Izdeş, S., Kayaaslan, B., Bayhan, G. İ., Emeksiz, S., Hasanoğlu, İ., Bektaş, Ş. G., Bütün Türk, Ş., Özcan, S., Ertürk, A., Akdağ, A. G., Yilmaz, A., & Haznedaroğlu, İ. C. (2023). Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome. Turkish Journal of Medical Sciences, 53(5), 1194-1204. https://doi.org/10.55730/1300-0144.5685
Vancouver
Şenel E, Türk S, Malkan ÜY, Peker MÇ, Türk C, Güner HR, et al. Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome. Turkish Journal of Medical Sciences. 2023;53(5):1194-1204. doi:10.55730/1300-0144.5685
BibTeX
@article{enel2023,
author = {Şenel, Emrah and Türk, Seyhan and Malkan, Ümit Yavuz and Peker, Mustafa Çağrı and Türk, Can and Güner, Hatice Rahmet and Uçar, Gülberk and Izdeş, Seval and Kayaaslan, Bircan and Bayhan, Gülsüm İclal and Emeksiz, Serhat and Hasanoğlu, İmran and Bektaş, Şerife Gökbulut and Bütün Türk, Şeyma and Özcan, Serhan and Ertürk, Ahmet and Akdağ, Ahmet Gökhan and Yilmaz, Ayşegül and Haznedaroğlu, İbrahim Celalettin},
title = {Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome},
journal = {Turkish Journal of Medical Sciences},
year = {2023},
volume = {53},
number = {5},
pages = {1194--1204},
doi = {10.55730/1300-0144.5685}
}
EUVIMED